258 related articles for article (PubMed ID: 16237241)
1. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
Booth J; Zavgorodni S
Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
3. Application of dose compensation in image-guided radiotherapy of prostate cancer.
Wu Q; Liang J; Yan D
Phys Med Biol; 2006 Mar; 51(6):1405-19. PubMed ID: 16510952
[TBL] [Abstract][Full Text] [Related]
4. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
5. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
Schwarz M; Lebesque JV; Mijnheer BJ; Damen EM
Radiother Oncol; 2004 Nov; 73(2):209-18. PubMed ID: 15542168
[TBL] [Abstract][Full Text] [Related]
7. Adjoint Monte Carlo method for prostate external photon beam treatment planning: an application to 3D patient anatomy.
Wang B; Goldstein M; Xu XG; Sahoo N
Phys Med Biol; 2005 Mar; 50(5):923-35. PubMed ID: 15798265
[TBL] [Abstract][Full Text] [Related]
8. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
9. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
11. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
Hille A; Töws N; Schmidberger H; Hess CF
Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
[TBL] [Abstract][Full Text] [Related]
12. Variation in target and rectum dose due to prostate deformation: an assessment by repeated MR imaging and treatment planning.
Kerkhof EM; van der Put RW; Raaymakers BW; van der Heide UA; van Vulpen M; Lagendijk JJ
Phys Med Biol; 2008 Oct; 53(20):5623-34. PubMed ID: 18799831
[TBL] [Abstract][Full Text] [Related]
13. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
14. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer.
Chen L; Paskalev K; Xu X; Zhu J; Wang L; Price RA; Hu W; Feigenberg SJ; Horwitz EM; Pollack A; Ma CM
Radiother Oncol; 2010 May; 95(2):198-202. PubMed ID: 20303193
[TBL] [Abstract][Full Text] [Related]
15. Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations.
Zhang M; Moiseenko V; Liu M; Craig T
Phys Med Biol; 2006 Jan; 51(2):269-85. PubMed ID: 16394338
[TBL] [Abstract][Full Text] [Related]
16. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
Su A; Blend MJ; Spelbring D; Hamilton RJ; Jani AB
Clin Nucl Med; 2006 Mar; 31(3):139-44. PubMed ID: 16495731
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric verification of IMRT treatment planning using Monte Carlo simulations for prostate cancer.
Yang J; Li J; Chen L; Price R; McNeeley S; Qin L; Wang L; Xiong W; Ma CM
Phys Med Biol; 2005 Mar; 50(5):869-78. PubMed ID: 15798261
[TBL] [Abstract][Full Text] [Related]
18. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer.
Hoogeman MS; van Herk M; de Bois J; Lebesque JV
Radiother Oncol; 2005 Feb; 74(2):177-85. PubMed ID: 15734206
[TBL] [Abstract][Full Text] [Related]
19. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy.
Fiorino C; Foppiano F; Franzone P; Broggi S; Castellone P; Marcenaro M; Calandrino R; Sanguineti G
Radiother Oncol; 2005 Feb; 74(2):187-95. PubMed ID: 15734207
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
